January 21, 2026
Comprehensive Chromosomal Screening CCS: IVF Nurses’ Essential Guide
Comprehensive Chromosomal Screening (CCS) tests all 23 chromosomes in IVF embryos, improving pregnancy success rates and reducing risks of miscarriage and multiple births. At RMANJ, CCS is available to all patients, including low responders and older individuals, with over 50% opting for single embryo transfers (SET) after screening. Studies show SET with CCS matches the success rates of transferring two unscreened embryos.
Key Takeaways
CCS Eligibility for IVF Patients: Who Benefits Most?
All IVF patients, including low responders and those with recurrent pregnancy loss, are eligible for CCS. The procedure provides critical data about embryo chromosomal health, preventing failed transfers and miscarriages. Older patients (35+ years) and those with unexplained infertility benefit most due to higher aneuploidy risks.
Boosting Single Embryo Transfers (SET) with CCS: Reducing Twin Risk
CCS enables safer single embryo transfers by identifying chromosomally normal embryos. At RMANJ, over 50% of patients choose SET post-CCS, achieving equivalent pregnancy rates to traditional double embryo transfers while eliminating twin pregnancy risks. This aligns with clinical goals for singleton births.
CCS for Recurrent Pregnancy Loss Patients: Selecting Healthy Embryos
Patients with multiple pregnancy losses often choose CCS to transfer chromosomally normal embryos. This reduces the likelihood of implantation failure due to aneuploidy, a leading cause of early miscarriage. For couples struggling with unexplained losses, CCS provides actionable data for informed decisions.
Optimal Embryo Transfer Timing with CCS: Syncing with Uterine Lining
Nurses must delay biopsy until embryos reach blastocyst stage to avoid developmental asynchrony. Morula-stage embryos are cultured until day 6, then biopsied and cryopreserved if transfer timing is mismatched. This prevents dyssynchrony and preserves embryo viability for later use.
CCS as a Bridge to Donor Eggs or Adoption: Empowering Patient Decisions
When multiple embryos are aneuploid, CCS provides objective evidence to support transitions to donor eggs or adoption. This reduces emotional distress by validating that all personal options have been exhausted. Nurses play a critical role in counseling patients through this decision-making process.
Source: Read full article